ArticleCancer chemotherapy and pharmacology2024

Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells.

Yoshihito Morimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.